One of the most illustrative examples of biomarker utilization is the measurement of cardiac troponin I (cTnI) levels in the diagnosis of myocardial infarction, as well as in the evaluation of patients presenting with chest pain and acute coronary syndrome (ACS), a pivotal practice discussed by [11]. The gene discussed is TNNI3; the disease is myocardial infarction.